Document is current
Any future updates will be listed below
-
Authors
Zhang, Rongyu
Qi, Jingqi
McKasson, Michaela
Choi, Jongchan https://orcid.org/0000-0003-0394-9978
Gutierrez, Vanessa
Brennan, Conor
Hong, Sunga https://orcid.org/0000-0003-4412-2811
Chour, William https://orcid.org/0000-0003-1817-0123
Ng, Rachel H. https://orcid.org/0000-0003-3692-8524
Xie, Jingyi
Yuan, Dan
Webster, Andrew
Sidhu, Simranjeet K.
Anderson, Abby
Chen, Daniel https://orcid.org/0000-0001-6660-6257
Edmark, Rick
Murray, Kim M.
Li, Sarah
McDonald, Connor
Rowen, Lee
Wang, Shuo
Rasheed, Yusuf
Su, Yapeng
Wagner, Jamie R.
Chen, Jia Ming https://orcid.org/0000-0003-3992-9143
Nawaly, Karla
Fu, Jie
Duven, Alexandria
Forman, Stephen J. https://orcid.org/0000-0002-2803-4152
Song, Mihae https://orcid.org/0000-0001-6457-6023
Priceman, Saul J. https://orcid.org/0000-0002-8136-2112
Brown, Christine E. https://orcid.org/0000-0003-4915-8207
Ribas, Antoni https://orcid.org/0000-0003-3669-8458
Wong, Deborah J.
Paulson, Kelly G.
Drescher, Charles W.
Puig-Saus, Cristina https://orcid.org/0000-0002-3014-3649
Goldman, Jason D. https://orcid.org/0000-0002-3825-6832
Trimble, Cornelia L. https://orcid.org/0000-0003-0397-5295
Heath, James R. https://orcid.org/0000-0001-5356-4385
- License Information
-
More Information
Article History
Received: 30 September 2025
Accepted: 15 April 2026
First Online: 12 May 2026
Competing interests
: C.P.-S. has received honoraria from Merck, Kyowa Kirin, and ImmPACT Bio. J.D.G. has consulted for Gilead, Merck, Ivivyd, obtained grants from Gilead and has contracted research with Gilead and Helix. J.R.H. is a consultant to Regeneron and has received research support from Gilead and Merck. A.R. has received honoraria from consulting with Amgen and Merck, is or has been a member of the scientific advisory board and holds stock in Appia, Apricity, Arcus, Compugen, CytomX, ImaginAb, ImmPact, Inspirna, Kite-Gilead, Larkspur, Lyell, Lutris, MapKure, Merus, Synthekine, and Tango, has received research funding from Agilent and from Bristol Myers Squibb through Stand Up to Cancer (SU2C), and patent royalties from Arsenal Bio. The remaining authors declare no competing interests.
